These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 16966705)

  • 1. Alterations in intestinal permeability.
    Arrieta MC; Bistritz L; Meddings JB
    Gut; 2006 Oct; 55(10):1512-20. PubMed ID: 16966705
    [No Abstract]   [Full Text] [Related]  

  • 2. Impaired intestinal molecular tightness in the mucosa of irritable bowel syndrome: what are the mediators?
    Vicario M; Alonso C; Santos J
    Gut; 2009 Feb; 58(2):161-2. PubMed ID: 19136518
    [No Abstract]   [Full Text] [Related]  

  • 3. [Disturbance of bile acid metabolism in intestinal diseases].
    Loginov AS; Krums LM; Fam Tkhi Tkhu Kho
    Vopr Pitan; 1980; (2):11-6. PubMed ID: 7368667
    [No Abstract]   [Full Text] [Related]  

  • 4. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
    Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
    Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome.
    Coëffier M; Gloro R; Boukhettala N; Aziz M; Lecleire S; Vandaele N; Antonietti M; Savoye G; Bôle-Feysot C; Déchelotte P; Reimund JM; Ducrotté P
    Am J Gastroenterol; 2010 May; 105(5):1181-8. PubMed ID: 19997094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal permeability and irritable bowel syndrome.
    Camilleri M; Gorman H
    Neurogastroenterol Motil; 2007 Jul; 19(7):545-52. PubMed ID: 17593135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional bowel symptoms in quiescent inflammatory bowel disease: more than just irritable bowel syndrome?
    Gracie DJ; Ford AC
    Gastroenterology; 2014 Nov; 147(5):1176-7. PubMed ID: 25240166
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial: abnormal permeability and altered mucosal serotonin metabolism in the irritable bowel syndrome - is there a link?
    Spiller R
    Aliment Pharmacol Ther; 2014 Nov; 40(9):1116-8. PubMed ID: 25280258
    [No Abstract]   [Full Text] [Related]  

  • 9. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.
    Piche T; Barbara G; Aubert P; Bruley des Varannes S; Dainese R; Nano JL; Cremon C; Stanghellini V; De Giorgio R; Galmiche JP; Neunlist M
    Gut; 2009 Feb; 58(2):196-201. PubMed ID: 18824556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations.
    Martínez C; Vicario M; Ramos L; Lobo B; Mosquera JL; Alonso C; Sánchez A; Guilarte M; Antolín M; de Torres I; González-Castro AM; Pigrau M; Saperas E; Azpiroz F; Santos J
    Am J Gastroenterol; 2012 May; 107(5):736-46. PubMed ID: 22415197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the alterations in the interstitial cells of Cajal on intestinal motility in post-infection irritable bowel syndrome.
    Yang B; Zhou XC; Lan C
    Mol Med Rep; 2015 Apr; 11(4):2735-40. PubMed ID: 25484117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fat absorption and malabsorption.
    Glickman RM
    Clin Gastroenterol; 1983 May; 12(2):323-34. PubMed ID: 6347460
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical relevance of proteinase activated receptors (pars) in the gut.
    Vergnolle N
    Gut; 2005 Jun; 54(6):867-74. PubMed ID: 15888798
    [No Abstract]   [Full Text] [Related]  

  • 14. Butyrate and type 1 diabetes mellitus: can we fix the intestinal leak?
    Li N; Hatch M; Wasserfall CH; Douglas-Escobar M; Atkinson MA; Schatz DA; Neu J
    J Pediatr Gastroenterol Nutr; 2010 Oct; 51(4):414-7. PubMed ID: 20706153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leaking gut in type 1 diabetes.
    Vaarala O
    Curr Opin Gastroenterol; 2008 Nov; 24(6):701-6. PubMed ID: 19122519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
    Martínez C; Lobo B; Pigrau M; Ramos L; González-Castro AM; Alonso C; Guilarte M; Guilá M; de Torres I; Azpiroz F; Santos J; Vicario M
    Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passage of molecules through the wall of the gastrointestinal tract. Intestinal permeability to polyethyleneglycol 1 000 in patients with Crohn's disease.
    Heuman R; Sjödahl R; Tagesson C
    Acta Chir Scand; 1982; 148(3):281-4. PubMed ID: 7136430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crohn's disease--a permeability disorder of the tight junction?
    Hollander D
    Gut; 1988 Dec; 29(12):1621-4. PubMed ID: 3065154
    [No Abstract]   [Full Text] [Related]  

  • 19. Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines.
    Drago S; El Asmar R; Di Pierro M; Grazia Clemente M; Tripathi A; Sapone A; Thakar M; Iacono G; Carroccio A; D'Agate C; Not T; Zampini L; Catassi C; Fasano A
    Scand J Gastroenterol; 2006 Apr; 41(4):408-19. PubMed ID: 16635908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes of tight junction claudin-1,-3,-4 protein expression in the intestinal mucosa in patients with irritable bowel syndrome].
    Kong WM; Gong J; Dong L; Xu JR
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1345-7. PubMed ID: 17884774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.